Highlights from ACR Convergence 2023

View American College of Rheumatology educational opportunities here - https://rheumatology.org/events-programs

 

RheumNow
P

ACR Convergence 2023 Highlights: The FOREMOST Study: Apremilast in PsA

By RheumNow FEATURING Peter Nash
By RheumNow FEATURING Peter Nash
0 views
November 22, 2023

The above content is not sponsored by, nor part of, the American College of Rheumatology.

Comments 0
Login to view comments. Click here to Login
Spondyloarthropathies
06:48
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: The Burden of Oligoarticular Psoria…

Feat. D. Gladman
16:37
Highlights from ACR Convergence 2023

​​ACR Convergence 2023 Highlights: INVIGORATE-1 - Secukinumab for Tr…

Feat. A. Deodhar
10:23
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Opioid Prescription Rates in Patien…

Feat. H. Berk Degirmenci
09:27
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Interpretation of Disease-Specific …

Feat. X. Baraliakos
07:30
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Efficacy and Safety of Intravenous …

Feat. A. Kivitz
16:19
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Spondyloarthritis - Comparing Adult…

Feat. H. Srinivasalu
06:14
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: The Use of the ASAS Referral Criter…

Feat. A. Chan
16:43
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: 2023 Classification Criteria for Ax…

Feat. P. Weiss
13:18
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: The Yield of Repeated Assessments i…

Feat. M. Marques
10:05
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Results of an Exploratory Analysis …

Feat. M. D'Agostino
11:18
Highlights from ACR Convergence 2023

ACR Convergence 2023 Highlights: Clinical Consequences of Infliximab…

Feat. M. Brun
05:25
RheumNow

​​ACR Convergence 2023 Highlights: INVIGORATE-1 Study: IV Secukinuma…

Feat. A. Deodhar
07:03
RheumNow

ACR Convergence 2023 Highlights: Correlation Between Patient and Phy…

Feat. A. Chan, A. Maroof
08:29
RheumNow

ACR Convergence 2023 Highlights: Using Telemedicine to Improve Diagn…

Feat. A. Chan, D. Poddubnyy
04:28
RheumNow

ACR Convergence 2023 Highlights: Deep Neural Networks and Radiograph…

Feat. A. Chan
04:53
RheumNow

ACR Convergence 2023 Highlights: Undiagnosed IBD in AxSpA

Feat. E. Dein
04:41
RheumNow

ACR Convergence 2023 Highlights: The FOREMOST Study: Apremilast in P…

Feat. P. Nash
04:16
RheumNow

ACR Convergence 2023 Highlights: Difficult to Treat axSpA

Feat. P. Nash
07:04
RheumNow

ACR Convergence 2023 Highlights: Imaging Updates in SpA

Feat. R. Tate, C. Blakewell
08:43
RheumNow

ACR Convergence 2023 Highlights: Teledidactic vs On Campus Training …

Feat. A. Chan, V. Schäfer
05:14
RheumNow

ACR Convergence 2023 Highlights: Treatments in SpA

Feat. R. Tate, C. Blakewell
04:08
RheumNow

ACR Convergence 2023 Highlights: Bimekizumab in Active AS: 5 Year St…

Feat. A. Deodhar
04:52
RheumNow

ACR Convergence 2023 Highlights: SpaA Updates: Anti-infliximab Antib…

Feat. E. Dein
48:24
RheumNow

ACR Convergence 2023 Highlights: SpA Topic Panel

Feat. S. Reyes, R. Tate, A. Chan, B. Mehta, J. Cush
33:00
RheumNow

ACR Convergence 2023 Highlights: JAK TYK2 Topic Panel

Feat. J. Cush, J. Pope, M. Putman, D. Liew
05:29
RheumNow

ACR Convergence 2023 Highlights: Two Studies: TAK-279 (Tyk2) in PsA …

Feat. G. Valenzuela